BRPI0214412B8 - solução aquosa contendo ácido glicônico, manitol e tween 80 para injeção de antagonista de hormônio liberador de gonadotrofina (lhrh), bem como seu processo de preparação - Google Patents
solução aquosa contendo ácido glicônico, manitol e tween 80 para injeção de antagonista de hormônio liberador de gonadotrofina (lhrh), bem como seu processo de preparaçãoInfo
- Publication number
- BRPI0214412B8 BRPI0214412B8 BRPI0214412A BR0214412A BRPI0214412B8 BR PI0214412 B8 BRPI0214412 B8 BR PI0214412B8 BR PI0214412 A BRPI0214412 A BR PI0214412A BR 0214412 A BR0214412 A BR 0214412A BR PI0214412 B8 BRPI0214412 B8 BR PI0214412B8
- Authority
- BR
- Brazil
- Prior art keywords
- injection
- lhrh
- aqueous solution
- tween
- mannitol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Manufacturing Of Micro-Capsules (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10157628A DE10157628A1 (de) | 2001-11-26 | 2001-11-26 | Injektionslösung eines LHRH-Antagonisten |
PCT/EP2002/012798 WO2003045419A1 (de) | 2001-11-26 | 2002-11-15 | Injektionslösung eines lhrh-antagonisten |
Publications (3)
Publication Number | Publication Date |
---|---|
BR0214412A BR0214412A (pt) | 2004-09-14 |
BRPI0214412B1 BRPI0214412B1 (pt) | 2016-01-05 |
BRPI0214412B8 true BRPI0214412B8 (pt) | 2021-05-25 |
Family
ID=7706799
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0214412A BRPI0214412B8 (pt) | 2001-11-26 | 2002-11-15 | solução aquosa contendo ácido glicônico, manitol e tween 80 para injeção de antagonista de hormônio liberador de gonadotrofina (lhrh), bem como seu processo de preparação |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1448221B1 (pt) |
JP (1) | JP4343693B2 (pt) |
KR (1) | KR100936636B1 (pt) |
CN (1) | CN100404068C (pt) |
AR (1) | AR037424A1 (pt) |
AT (1) | ATE350050T1 (pt) |
AU (1) | AU2002365504B2 (pt) |
BR (1) | BRPI0214412B8 (pt) |
CO (1) | CO5580793A2 (pt) |
CY (1) | CY1106401T1 (pt) |
DE (2) | DE10157628A1 (pt) |
DK (1) | DK1448221T3 (pt) |
EA (1) | EA010787B1 (pt) |
ES (1) | ES2276970T3 (pt) |
GE (1) | GEP20063861B (pt) |
HK (1) | HK1073078A1 (pt) |
HR (1) | HRP20040587B1 (pt) |
HU (1) | HU230992B1 (pt) |
IL (2) | IL161894A0 (pt) |
IS (1) | IS2725B (pt) |
ME (1) | ME00499B (pt) |
MX (1) | MXPA04005018A (pt) |
NO (1) | NO333364B1 (pt) |
NZ (1) | NZ533712A (pt) |
PL (1) | PL206199B1 (pt) |
PT (1) | PT1448221E (pt) |
RS (1) | RS51408B (pt) |
RU (1) | RU2322969C2 (pt) |
SI (1) | SI1448221T1 (pt) |
TW (1) | TWI312283B (pt) |
UA (1) | UA81612C2 (pt) |
WO (1) | WO2003045419A1 (pt) |
ZA (1) | ZA200404051B (pt) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8119159B2 (en) | 1999-02-22 | 2012-02-21 | Merrion Research Iii Limited | Solid oral dosage form containing an enhancer |
US7658938B2 (en) | 1999-02-22 | 2010-02-09 | Merrion Reasearch III Limited | Solid oral dosage form containing an enhancer |
EP2007397B1 (en) | 2006-04-07 | 2013-07-24 | Merrion Research III Limited | Solid oral dosage form containing an enhancer |
US8999383B2 (en) * | 2008-05-07 | 2015-04-07 | Merrion Research Iii Limited | Compositions of GnRH related compounds and processes of preparation |
WO2011120033A1 (en) | 2010-03-26 | 2011-09-29 | Merrion Research Iii Limited | Pharmaceutical compositions of selective factor xa inhibitors for oral administration |
US8802114B2 (en) | 2011-01-07 | 2014-08-12 | Merrion Research Iii Limited | Pharmaceutical compositions of iron for oral administration |
CN103690560B (zh) * | 2013-12-17 | 2016-08-17 | 辽宁海思科制药有限公司 | 一种转化糖电解质注射液药物组合物及其制备方法 |
JP7211704B2 (ja) | 2015-01-29 | 2023-01-24 | ノヴォ ノルディスク アー/エス | Glp-1アゴニスト及び腸溶コーティングを含む錠剤 |
RU2614234C2 (ru) * | 2015-03-31 | 2017-03-23 | Федеральное государственное бюджетное учреждение науки Институт общей генетики им. Н.И. Вавилова Российской академии наук (ИОГЕН РАН) | Фармацевтическая композиция на основе 3-(4-Метилимидазол-1-ил)имидазо[1,2-b][1,2,4,5]тетразина в качестве противоопухолевого средства |
US20180214506A1 (en) * | 2017-01-30 | 2018-08-02 | Antev Limited | Combination administration of gnrh antagonists |
US20210121517A1 (en) | 2019-10-24 | 2021-04-29 | Sun Pharmaceutical Industries Limited | Stable parenteral dosage form of cetrorelix acetate |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4800191A (en) * | 1987-07-17 | 1989-01-24 | Schally Andrew Victor | LHRH antagonists |
US5140009A (en) * | 1988-02-10 | 1992-08-18 | Tap Pharmaceuticals, Inc. | Octapeptide LHRH antagonists |
US5300492A (en) * | 1988-02-10 | 1994-04-05 | Tap Pharmaceuticals | LHRH analogs |
PL201898B1 (pl) * | 1999-09-23 | 2009-05-29 | Zentaris Gmbh | Zastosowanie antagonisty LH-RH w leczeniu endometriozy |
DE10024451A1 (de) * | 2000-05-18 | 2001-11-29 | Asta Medica Ag | Pharmazeutische Darreichungsform für Peptide, Verfahren zu deren Herstellung und Verwendung |
-
2001
- 2001-11-26 DE DE10157628A patent/DE10157628A1/de not_active Withdrawn
-
2002
- 2002-11-15 AT AT02790384T patent/ATE350050T1/de active
- 2002-11-15 GE GE5568A patent/GEP20063861B/en unknown
- 2002-11-15 JP JP2003546920A patent/JP4343693B2/ja not_active Expired - Lifetime
- 2002-11-15 KR KR1020047007807A patent/KR100936636B1/ko active IP Right Grant
- 2002-11-15 PT PT02790384T patent/PT1448221E/pt unknown
- 2002-11-15 ES ES02790384T patent/ES2276970T3/es not_active Expired - Lifetime
- 2002-11-15 BR BRPI0214412A patent/BRPI0214412B8/pt not_active IP Right Cessation
- 2002-11-15 DK DK02790384T patent/DK1448221T3/da active
- 2002-11-15 HU HU0401986A patent/HU230992B1/hu unknown
- 2002-11-15 SI SI200230505T patent/SI1448221T1/sl unknown
- 2002-11-15 UA UA20040503816A patent/UA81612C2/ru unknown
- 2002-11-15 NZ NZ533712A patent/NZ533712A/en not_active IP Right Cessation
- 2002-11-15 EA EA200400742A patent/EA010787B1/ru unknown
- 2002-11-15 WO PCT/EP2002/012798 patent/WO2003045419A1/de active IP Right Grant
- 2002-11-15 CN CNB028234901A patent/CN100404068C/zh not_active Expired - Lifetime
- 2002-11-15 ME MEP-2008-800A patent/ME00499B/me unknown
- 2002-11-15 DE DE50209193T patent/DE50209193D1/de not_active Expired - Lifetime
- 2002-11-15 MX MXPA04005018A patent/MXPA04005018A/es active IP Right Grant
- 2002-11-15 RS YUP-449/04A patent/RS51408B/sr unknown
- 2002-11-15 EP EP02790384A patent/EP1448221B1/de not_active Expired - Lifetime
- 2002-11-15 IL IL16189402A patent/IL161894A0/xx unknown
- 2002-11-15 AU AU2002365504A patent/AU2002365504B2/en not_active Expired
- 2002-11-15 PL PL369548A patent/PL206199B1/pl unknown
- 2002-11-15 RU RU2004119821/15A patent/RU2322969C2/ru active
- 2002-11-20 TW TW091133846A patent/TWI312283B/zh not_active IP Right Cessation
- 2002-11-25 AR ARP020104523A patent/AR037424A1/es not_active Application Discontinuation
-
2004
- 2004-05-06 IS IS7251A patent/IS2725B/is unknown
- 2004-05-10 IL IL161894A patent/IL161894A/en active IP Right Grant
- 2004-05-14 CO CO04044748A patent/CO5580793A2/es not_active Application Discontinuation
- 2004-05-25 ZA ZA2004/04051A patent/ZA200404051B/en unknown
- 2004-06-11 NO NO20042449A patent/NO333364B1/no not_active IP Right Cessation
- 2004-06-24 HR HR20040587A patent/HRP20040587B1/xx not_active IP Right Cessation
-
2005
- 2005-07-11 HK HK05105809.5A patent/HK1073078A1/xx not_active IP Right Cessation
-
2007
- 2007-03-20 CY CY20071100391T patent/CY1106401T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0214412B8 (pt) | solução aquosa contendo ácido glicônico, manitol e tween 80 para injeção de antagonista de hormônio liberador de gonadotrofina (lhrh), bem como seu processo de preparação | |
ES2561108T3 (es) | Composiciones inyectables para la liberación controlada de compuesto farmacológicamente activo | |
TW200628157A (en) | Storage stable perfusion solution for dihydropteridinones | |
AR100291A2 (es) | Composición catártica | |
BRPI0014869B8 (pt) | prostaglandinas bicíclicas, composições estabilizadas das mesmas, bem como processo para sua estabilização | |
CA2331009A1 (en) | Compositions and methods of treatment for conditions responsive to testosterone elevation | |
US20070161571A1 (en) | Injection solution of an LHRH antagonist | |
BRPI0009249A (pt) | formulação farmacêutica parenteral de equinocandina contendo tensoativos de formação de micela. | |
CN102821782A (zh) | 促卵泡激素的液体配制品 | |
PE20011223A1 (es) | Composicion farmaceutica que comprende pemetrexed y un antioxidante como monotioglicerol, l-cisteina y acido tioglicolico | |
PE20011188A1 (es) | El uso de composiciones a base de antibioticos de azalidos para tratar o prevenir una infeccion bacteriana o protozoaria en mamiferos | |
JPS62158209A (ja) | 液状ユビキノン薬剤組成物 | |
RU2008146217A (ru) | Фармацевтическая композиция, содержащая производное таксана, которая предназначена для приготовления инфузионного раствора, способ его приготовления и использование | |
CO5540279A2 (es) | Formulacion liofilitada de 2-metil-tieno-benzodiazepina | |
CA2406179A1 (en) | Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors | |
CO5021217A1 (es) | Composiciones estables de mitoxantrona, procedimietno para prepararlas; utilizacion de dichas composiciones y medica- mentos que incluyen dichas soluciones para el tratamiento de enfermedades cancerosas | |
BRPI0416535A (pt) | processo de congelamento por vaporização empregando um extrusor para preparar composições de azitromicina de multiparticulado contendo preferivelmente um poloxámero e um glicerìdeo | |
PE20011320A1 (es) | Suspension esteroidal estabilizada | |
JP2003502361A5 (pt) | ||
CN105579055A (zh) | Lhrh类似物的水性缓释组合物 | |
DE60135845D1 (de) | Pralmorelin-haltige nasentropfen-präparate | |
WO2004075834A3 (en) | Stabilized pharmaceutical compositions of safingol and methods of using the same | |
CN107987980A (zh) | 一种无磷环保洗衣粉 | |
WO2001003774A3 (en) | Pharmaceutical composition for the treatment of calcification | |
CN1626078A (zh) | 替硝唑粉针剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: AETERNA ZENTARIS GMBH (DE) Free format text: ALTERADO DE: ZENTARIS GMBH |
|
B25A | Requested transfer of rights approved |
Owner name: ZENTARIS IVF GMBH (DE) Free format text: TRANSFERIDO DE: AETERNA ZENTARIS GMBH |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/01/2016, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/11/2002 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 15/11/2022 |